Effect of cocaine and amphetamine on biosynthesis of proenkephalin and prodynorphin in some regions of the rat limbic system

Polish Journal of Pharmacology

Volumn 54, Issue 4, 2002, Pages 367-372

  Turchan, Jadwiga ^a   Maj, Marcin ^a   Przewłocka, Barbara ^a   Przewłocki, Ryszard ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Amphetamine; Amygdala; Cocaine; Hippocampus; Prodynorphin mRNA; Proenkephalin mRNA

Indexed keywords

AMPHETAMINE; COCAINE; DEXAMPHETAMINE; MESSENGER RNA; OPIATE RECEPTOR; PRODYNORPHIN; PROENKEPHALIN; ENKEPHALIN; PREPROENKEPHALIN; PROTEIN PRECURSOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENTATE NUCLEUS; DRUG DEPENDENCE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; LIMBIC SYSTEM; MALE; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; PEPTIDE SYNTHESIS; PEPTIDERGIC NERVOUS SYSTEM; PROTEIN LOCALIZATION; RAT; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; IN SITU HYBRIDIZATION; METABOLISM; WISTAR RAT;

AMPHETAMINE; ANIMALS; COCAINE; ENKEPHALINS; IN SITU HYBRIDIZATION; LIMBIC SYSTEM; MALE; PROTEIN PRECURSORS; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 0036384926     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Alheid G.F., Heimer L.: Theories of basal forebrain organization and the "emotional motor system". Prog. Brain Res., 1996, 107, 461-484.
2. Bohus B., Koolhaas J.M., Luiten P.G., Korte S.M., Roozendaal B., Wiersma A.: The neurobiology of the central nucleus of the amygdala in relation to neuroendocrine and autonomic outflow. Prog. Brain Res., 1996, 107, 447-460.
3. Calvino B., Lagowska J., Ben-Ari Y.: Morphine withdrawal syndrome: differential participation of structures located within the amygdaloid complex and striatum of the rat. Brain Res., 1979, 177, 19-34.
4. Cassell M.D., Gray T.S.: Morphology of peptide-immunoreactive neurons in the rat central nucleus of the amygdala. J. Comp. Neurol., 1989, 281, 320-333.
5. Couceyro P., Shoaib M., McCoy M., Goldberg S.R., Kuhar M.J.: Cocaine self-administration alters brain NADH dehydrogenase mRNA levels. NeuroReport, 1997, 8, 2437-2441.
6. Crespo J.A., Manzanares J., Oliva J.M., Corchero J., Palomo T, Ambrosio E.: Extinction of cocaine self-administration produces a differential time-related regulation of proenkephalin gene expression in rat brain. Neuropsychopharmacology, 2001, 25, 185-194.
7. Di Chiara G.: A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J Psychopharmacol., 1998, 12, 54-67.
8. Di Chiara G., Imperato A.: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Nat. Acad. Sci. USA, 1988, 85, 5274-5278.
9. Douglass J., Daoud S.: Characterization of the human cDNA and genomic DNA encoding CART: a cocaine-and amphetamine-regulated transcript. Gene, 1996, 169, 241-245.
10. Fagergren P., Hurd Y.L.: Mesolimbic gender differences in peptide CART mRNA expression: effects of cocaine. NeuroReport, 1999, 10, 3449-3452.
11. Fallon J.H., Leslie F.M.: Distribution of dynorphin and enkephalin peptides in the rat brain. J. Comp. Neurol., 1986, 249, 293-336.
12. Groenewegen H.J., Wright C.I., Beijer A.V.: The nucleus accumbens: gateway for limbic structures to reach the motor system? Prog. Brain Res., 1996, 107, 485-511.
13. Herz A.: Opioid reward mechanisms: a key role in drug abuse? Can. J. Physiol. Pharmacol., 1998, 76, 252-258.
14. Honkaniemi J., Pelto-Huikko M., Rechardt L., Isola J., Lammi A., Fuxe K., Gustafsson J.A., Wikstrom A.C., Hökfelt T.: Colocalization of peptide and glucocorticoid receptor immunoreactivities in rat central amygdaloid nucleus. Neuroendocrinology, 1992 55, 451-459.
15. Hurd Y.L., Brown E.E., Finlay J.M., Fibiger H.C., Gerfen C.R.: Cocaine self-administration differentially alters mRNA expression of striatal peptides. Mol. Brain Res., 1992, 13, 165-170.
16. Hurd YL., Herkenham M.: The human neostriatum shows compartmentalization of neuropeptide gene expression in dorsal and ventral regions: an in situ hybridization histochemical analysis. Neuroscience, 1995, 64, 571-586.
17. Hyman S.E.: Addiction to cocaine and amphetamine. Neuron, 1996, 16, 901-904.
18. Koob G.F.: Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci., 1992, 13, 177-184.
19. Koob G.F.: Drug addiction: the yin and yang of hedonic homeostasis. Neuron, 1996, 16, 893-896.
20. Koylu E.O., Couceyro P.R., Lambert P.D., Ling N.C., DeSouza E.B., Kuhar M.J.: Immunohistochemical localization of novel CART peptides in rat hypothalamus, pituitary and adrenal gland. J Neuroendocrinol., 1997, 9, 823-833.
21. Lesse H., Collins J.P.: Effects of cocaine on propagation of limbic seizure activity. Pharmacol. Biochem. Behav., 1979, 11, 689-694.
22. Samson H.H., Harris R.A.: Neurobiology of alcohol abuse. Trends Pharmacol. Sci., 1992, 13, 206-211.
23. Saper C.B.: Role of the cerebral cortex and striatum in emotional motor response. Prog. Brain Res., 1996, 107, 537-550.
24. Smith A.J., McGinty J.F.: Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum. Mol. Brain Res., 1994, 21, 359-362.
25. Song D.D., Harlan R.E.: The development of enkephalin and substance P neurons in the basal ganglia: insights into neostriatal compartments and the extended amygdala. Develop. Brain Res., 1994, 83, 247-261.
26. Spangler R., Unterwald E.M., Kreek M.J.: 'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Mol. Brain Res., 1993, 19, 323-327.
27. Svensson P., Hurd Y.L.: Specific reductions of striatal prodynorphin and D1 dopamine receptor messenger RNAs during cocaine abstinence. Mol. Brain Res., 1998, 56, 162-168.
28. Turchan J., Przewłocka B., Lasón W., Przewłocki R.: Effects of repeated psychostimulant administration on the prodynorphin system activity and kappa opioid receptor density in the rat brain. Neuroscience, 1998, 85, 1051-1059.
29. Unterwald E.M., Horne-King J., Kreek M.J.: Chronic cocaine alters brain mu opioid receptors. Brain Res., 1992, 84, 314-318.
30. Wise R.A., Bozarth M.A.: A psychomotor stimulant theory of addiction. Psychol. Rev., 1987, 94, 469-492.
31. Xi Z.X., Fuller S.A., Stein E.A.: Dopamine release in the nucleus accumbens during heroin self-administration is modulated by kappa opioid receptors: an in vivo fast-cyclic voltammetry study. J Pharmacol. Exp. Ther., 1998, 284, 151-161.
32. Young W.S. 3rd, Bonner T.I., Brann M.R.: Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. Nat. Acad. Sci. USA, 1986, 83, 9827-9831.
33. Ziółkowska B., Przewłocka B., Mika J., Łabuz D., Przewłocki R.: Evidence for Fos involvement in the regulation of proenkephalin and prodynorphin gene expression in the rat hippocampus. Mol. Brain Res., 1998, 54, 243-251.